Effects of oral contraception with ethinylestradiol and drospirenone on oxidative stress in women 18-35 years old.

[en] Background Oral contraceptives (OCs) with estrogens and progestins may affect oxidative stress (OS) status. Study design A group of 32 women using oral contraceptives (OCU) containing 0.03 mg ethinylestradiol and 3 mg drospirenone have been compared to a matched control group of 30 noncontraception users (NCU). Blood levels of antioxidants, trace elements and markers of lipid peroxidation were assessed by biochemical methods. A microarray analysis of whole blood mRNA levels of 200 genes involved in OS-dependant pathway was also performed. Results Levels of zinc, vitamin E and antibodies to oxidized low-density lipoproteins (LDLs) were not significantly different between the two groups. On the other hand, significant increases in the mean levels of lipid peroxides (+176%, p<.001), oxidized LDLs (+145%, p<.002), copper (+103%, p<.001), Cu/Zn ratio (+100%, p<.001) and a significant decrease in the mean level of β-carotene (−41%, p<.01) were observed in the OCU compared to NCU. There was a highly significant positive correlation between the lipid peroxide levels and the copper-to-zinc ratio. From the 200 genes tested by microarray, one coding for HSP70 was significantly up-regulated (log2 fold change=+ 0.45, p<.02) and one coding for inducible nitric oxide synthase significantly down-regulated (log2 fold change=−0.24, p<.05) in the OCU compared to the NCU. Conclusions The recently introduced combination of ethinylestradiol and drospirenone induced the heightening of lipid peroxidation correlated with high levels of copper, a situation that could be associated with increased cardiovascular risk.

Disciplines :

Reproductive medicine (gynecology, andrology, obstetrics)

Author, co-author :

De Groote, D.

PERRIER d'HAUTERIVE, Sophie ; Université de Liège - ULiège > Gynécologie-Obstétrique CHR

Pintiaux, Axelle ; Université de Liège - ULiège > Gynécologie-Obstétrique CHR

Balteau, Bénédicte ; Université de Liège - ULiège > Gynécologie-Obstétrique CHR

Gerday, Colette ; Université de Liège - ULiège > Gynécologie-Obstétrique CHR

Claesen, J.

Foidart, Jean-Michel ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie - Obstétrique - Labo de biologie des tumeurs et du développement

Language :

English

Title :

Effects of oral contraception with ethinylestradiol and drospirenone on oxidative stress in women 18-35 years old.

Publication date :

2009

Journal title :

Contraception

ISSN :

0010-7824

Publisher :

Elsevier, New York, United States - New York

Volume :

Issue :

Pages :

187-93

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 12 October 2009

Statistics

Number of views

227 (6 by ULiège)

Number of downloads

541 (2 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Fridovich I. The biology of oxygen radicals. Science 201 (1978) 875-880
Nohl H. Involvement of free radicals in ageing: a consequence or cause of senescence. Br Med Bull 49 (1993) 653-667
Urban T., Hurbain I., Urban M., Clement A., and Housset B. Oxidants and antioxidants. Biological effects and therapeutic perspectives. B Ann Chir 49 (1995) 427-434
Unfer T.C., Conterato G.M., da Silva J.C., Duarte M.M., and Emanuelli T. Influence of hormone replacement therapy on blood antioxidant enzymes in menopausal women. Clin Chim Acta 369 (2006) 73-77 [electronic publication 2006 Feb 10]
Ke R.W., Todd Pace D., and Ahokas R.A. Effect of short-term hormone therapy on oxidative stress and endothelial function in African American and Caucasian postmenopausal women. Fertil Steril 79 (2003) 1118-1122
Ozden S., Dildar K., Kadir Y.H., and Gulizar K. The effects of hormone replacement therapy on lipid peroxidation and antioxidant status. Maturitas 38 (2001) 165-170
Ahotupa M., Rauramo I., Vasankari T.J., Skouby S.O., and Hakonen T. Estrogen replacement therapy in combination with continuous intrauterine progestin administration reduces the amount of circulating oxidized LDL in postmenopausal women: dependence on the dose of progestin. Ann Med 36 (2004) 278-284
Topcuoglu A., Uzun H., Aydin S., et al. The effect of hormone replacement therapy on oxidized low density lipoprotein levels and paraoxonase activity in postmenopausal women. J Exp Med 205 (2005) 79-86
Bednarek-Tupikowska G., Tworowska U., Jedrychowska I., et al. Effects of oestradiol and oestroprogestin on erythrocyte antioxidative enzyme system activity in postmenopausal women. Clin Endocrinol (Oxf) 64 (2006) 463-468
Bednarek-Tupikowska G., Tupikowski K., Bidzińska B., et al. Serum lipid peroxides and total antioxidant status in postmenopausal women on hormone replacement therapy. Gynecol Endocrinol 19 (2004) 57-63
Heikkinen A.M., Niskanen L., Yla-Herttuala S., et al. Postmenopausal hormone replacement therapy and autoantibodies against oxidized LDL. Maturitas 29 (1998) 155-161
Wen Y., Doyle M.C., Norris L.A., et al. Combined oestrogen-progestogen replacement therapy does not inhibit low-density lipoprotein oxidation in postmenopausal women. Br J Clin Pharmacol 47 (1999) 315-321
Nenseter M.S., Volden V., Berg T., Drevon C.A., Ose L., and Tonstad S. Effect of hormone replacement therapy on the susceptibility of low-density lipoprotein to oxidation among postmenopausal hypercholesterolaemic women. Eur J Clin Invest 26 (1996) 1062-1068
Mc Manus J., Mc Eneny J., Thompson W., and Young I.S. The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women. Atherosclerosis 135 (1997) 73-81
Bureau I., Laporte F., Favier M., et al. No antioxidant effect of combined HRT on LDL oxidizability and oxidative stress biomarkers in treated post-menopausal women. J Am Coll Nutr 21 (2002) 333-338
Subakir S.B., Setiadi E., Affandi B., Pringgoutomo S., and Freisleben H.J. Benefits of vitamin E supplementation to Norplant users - in vitro and in vivo studies. Toxicology 148 (2000) 173-178
Subakir S.B., Abdul Madjid O., Sabariah S., and Affandi B. Oxidative stress, vitamin E and progestin breakthrough bleeding. Hum Reprod 15 Suppl 3 (2000) 18-23
Faddah L.M., Al-Rehany M.A., Abdel-Hamid N.M., and Bakeet A.A. Oxidative stress, lipid profile and liver functions in average Egyptian long term depo medroxy progesterone acetate (DMPA) users. Molecules 10 (2005) 1145-1152
Durand P., and Blache D. Enhanced platelet thromboxane synthesis and reduced macrophage-dependent fibrinolytic activity related to oxidative stress in oral contraceptive-treated female rats. Atherosclerosis 121 (1996) 205-216
Palan P.R., Magneson A.T., Castillo M., Dunne J., and Mikhail M.S. Effects of menstrual cycle and oral contraceptive use on serum levels of lipid-soluble antioxidants. Am J Obstet Gynecol 194 (2006) e35-e38 [electronic publication 2006 Apr 21]
Pincemail J., Vanbelle S., Gaspard U., et al. Effect of different contraceptive methods on the oxidative stress status in women aged 40-48 years from the ELAN study in the province of Liege, Belgium. Hum Reprod 22 (2007) 2335-2343 [electronic publication 2007 Jun 20]
Zhao B., Tham S.Y., Lu J., Lai M.H., Lee L.K., and Moochhala S.M. Simultaneous determination of vitamins C, E and beta-carotene in human plasma by high-performance liquid chromatography with photodiode-array detection. J Pharm Pharm Sci 7 (2004) 200-204
Stürup S., Hayes R.B., and Peters U. Development and application of a simple routine method for the determination of selenium in serum by octopole reaction system ICPMS. Anal Bioanal Chem 381 (2005) 686-694 [electronic publication 2005 Feb 9]
Huber W., Von Heydebreck A., Sultmann H., Poustka A., and Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18 (2002) S96-S104
Smyth G.K. Limma. Linear models for microarray data. In: Gentleman R., Carey V., Dudoit S., Irizarry R., and Huber W. (Eds). Bioinformatics and Computational Biology Solutions using R and Bioconductor (2005), Springer, New York 397-420
Lonnstedt I., and Speed T. Replicated microarray data. Stat Sinica 12 (2002) 31-46
Smyth G.K. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3 (2004) Article3
Wagner A.H., Schroeter M.R., and Hecker M. 17beta-estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB J 15 (2001) 2121-2130
Laufs U., Adam O., Strehlow K., et al. Down-regulation of Rac-1 GTPase by estrogen. J Biol Chem 278 (2003) 5956-5962 [electronic publication 2002 Dec 18]
Chambliss K.L., and Shaul P.W. Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev 23 (2002) 665-686
Strehlow K., Rotter S., Wassmann S., et al. Modulation of antioxidant enzyme expression and function by estrogen. Circ Res 93 (2003) 170-177 [electronic publication 2003 Jun 19]
Wassmann K., Wassmann S., and Nickenig G. Progesterone antagonizes the vasoprotective effect of estrogen on antioxidant enzyme expression and function. Circ Res 97 (2005) 1046-1054 [electronic publication 2005 Sep 29]
Itagaki T., Shimizu I., Cheng X., et al. Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells. Gut 54 (2005) 1782-1789
Gordon K.B., Macrae I.M., and Carswell H.V. Effects of 17beta-oestradiol on cerebral ischaemic damage and lipid peroxidation. Brain Res 1036 (2005) 155-162
Bhat H.K., Calaf G., Hei T.K., Loya T., and Vadgama J.V. Critical role of oxidative stress in estrogen-induced carcinogenesis. Proc Natl Acad Sci U S A 100 (2003) 3913-3918 [electronic publication 2003 Mar 24]
Prokai-Tatrai K., and Prokai L. Impact of metabolism on the safety of estrogen therapy. Ann N Y Acad Sci 1052 (2005) 243-257
Akhter S., Shamsuzzaman A.K., Banarjee M., Seema S.A., and Deb K. Serum copper in rural women taking combined oral contraceptive. Mymensingh Med J 15 (2006) 25-29
Berg G., Kohlmeier L., and Brenner H. Effect of oral contraceptive progestins on serum copper concentration. J Clin Nutr 52 (1998) 711-715
Benes B., Spevácková V., Smíd J., Batáriová A., Cejchanová M., and Zítková L. Effects of age, BMI, smoking and contraception on levels of Cu, Se and Zn in the blood of the population in the Czech Republic. Cent Eur J Public Health 13 (2005) 202-207
Uriu-Adams J.Y., and Keen C.L. Copper, oxidative stress, and human health. Mol Aspects Med 26 (2005) 268-298
Ferns G.A., Lamb D.J., and Taylor A. The possible role of copper ions in atherogenesis: the Blue Janus. Atherosclerosis 133 (1997) 139-152
Patel R.P., Svistunenko D., Wilson M.T., and Darley-Usmar V.M. Reduction of Cu (II) by lipid hydroperoxides: implications for the copper-dependent oxidation of low-density lipoprotein. Biochem J 322 (1997) 425-433
Bray T.M., and Bettger W.J. The physiological role of zinc as an antioxidant. Free Radic Biol Med 8 (1990) 281-291
Mezzetti A., Pierdomenico S.D., Costantini F., et al. Copper/zinc ratio and systemic oxidant load: effect of aging and aging-related degenerative diseases. Free Radic Biol Med 25 (1998) 676-681
Kim S.H., Lee S.U., Kim M.H., Kim B.T., and Min Y.K. Mitogenic estrogen metabolites alter the expression of 17beta-estradiol-regulated proteins including heat shock proteins in human MCF-7 breast cancer cells. Mol Cells 20 (2005) 378-384
Yu H.P., Shimizu T., Choudhry M.A., et al. Mechanism of cardioprotection following trauma-hemorrhagic shock by a selective estrogen receptor-beta agonist: up-regulation of cardiac heat shock factor-1 and heat shock proteins. J Mol Cell Cardiol 40 (2006) 185-194
Matz J.M., Blake M.J., Saari J.T., and Bode A.M. Dietary copper deficiency reduces heat shock protein expression in cardiovascular tissues. FASEB J 8 (1994) 97-102
Moreland J.J., Arrieta D.E., and Washburn B.S. Effects of estrogen on the stress response in CuSO4-exposed PLHC-1 cells. Mar Environ Res 50 (2000) 509-512
Sunday L., Tran M.M., Krause D.N., and Duckles S.P. Estrogen and progestagens differentially modulate vascular proinflammatory factors. Am J Physiol Endocrinol Metab 291 (2006) E261-E267
Zicari A., Centonze C., Realacci M., Buchetti B., Pietropolli A., and Ticconi C. Estradiol 17-beta and progesterone modulate inducible nitric oxide synthase and high mobility group box 1 expression in human endometrium. Reprod Sci 15 (2008) 559-566
Müller E., and Kerschbaum H.H. Progesterone and its metabolites 5-dihydroprogesterone and 5-3-tetrahydroprogesterone decrease LPS-induced NO release in the murine microglial cell line, BV-2. Neuro Endocrinol Lett 27 (2006) 675-678
Karpuzoglu E., Fenaux J.B., Phillips R.A., Lengi A.J., Elvinger F., and Ansar Ahmed S. Estrogen up-regulates inducible nitric oxide synthase, nitric oxide, and cyclooxygenase-2 in splenocytes activated with T cell stimulants: role of interferon-gamma. Endocrinol 147 (2006) 662-671
Powell S.R. The antioxidant properties of zinc. J Nutr 130 5S Suppl (2000) 1447S-1454S
Gaetke L.M., and Chow C.K. Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology 189 (2003) 147-163
Mooij P.N., Thomas C.M., Doesburg W.H., and Eskes T.K. Multivitamin supplementation in oral contraceptive users. Contraception 44 (1991) 277-288
Singh U., and Jialal I. Oxidative stress and atherosclerosis. Pathophysiology 13 (2006) 129-142
Kovacs I.B., Jahangiri M., Rees G.M., and Gorog P. Elevated plasma lipid hydroperoxides in patients with coronary artery disease. Am Heart J 134 (1997) 572-576
Gorog D.A., Ahmed N., and Davies G.J. Elevated plasma lipid peroxide levels in angina pectoris and myocardial infarction. Cardiovasc Pathol 11 (2002) 153-157
Rumley A.G., Woodward M., Rumley A., Rumley J., and Lowe G.D. Plasma lipid peroxides: relationships to cardiovascular risk factors and prevalent cardiovascular disease. QJM 97 (2004) 809-816
Keaney Jr. J.F., Larson M.G., Vasan R.S., et al. Framingham Study. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 23 (2003) 434-439 [electronic publication 2003 Jan 30]
Cameron V.A., Mocatta T.J., Pilbrow A.P., et al. Angiotensin type-1 receptor A1166C gene polymorphism correlates with oxidative stress levels in human heart failure. Hypertension 47 (2006) 1155-1161 [electronic publication 2006 May 1]
Li J., Wang X., Huo Y., et al. PON1 polymorphism, diabetes mellitus, obesity, and risk of myocardial infarction: modifying effect of diabetes mellitus and obesity on the association between PON1 polymorphism and myocardial infarction. Genet Med 7 (2005) 58-63
Kinnula V.L., Lehtonen S., Koistinen P., et al. Two functional variants of the superoxide dismutase genes in Finnish families with asthma. Thorax 59 (2004) 116-119
Stenvinkel P., Pecoits-Filho R., Lindholm B., and for the DialGene Consortium. Gene polymorphism association studies in dialysis: the nutrition-inflammation axis. Semin Dial 18 (2005) 322-330
Balkan J., Kanbaǧli O., Mehmetçik G., Mutlu-Türkoǧlu U., Aykaç-Toker G., and Uysal M. Increased lipid peroxidation in serum and low-density lipoproteins associated with aging in humans. Int J Vitam Nutr Res 72 (2002) 315-320
Kasapoglu M., and Ozben T. Alterations of antioxidant enzymes and oxidative stress markers in aging. Exp Gerontol 36 (2001) 209-220
Del Corso L., Pastine F., Protti M.A., et al. Blood zinc, copper and magnesium in aging. A study in healthy home-living elderly. Panminerva Med 42 (2000) 273-277